Prostate Cancer Studies Currently Recruiting Participants at the University of Chicago Comprehensive Cancer Center

Study Number Title
10-174-B Feasibility of Collection & Analysis of Circulating and Disseminated Tumor Cells from men with Advanced Prostate Cancer
Select
10-487-A The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
Select
10-662-B A phase I, open-label study of the safety and pharmacokinetics of escalating doses of DSTP3086S in patients with metastatic castration-resistant prostate cancer
Select
10-625-A A feasibility study of oral hormonal therapy and radiation for non-metastatic, intermediate or high risk prostate cancer in men 70 and older or with medical comorbidities
Select
11-0110 CALGB 70807: The Men¿s Eating and Living (MEAL) Study: A Randomized Trial of Diet to Alter Disease Progression in Prostate Cancer Patients on Active Surveillance
11-0061 Evaluation of endorectal MRI for risk stratification, treatment planning, and workup after biochemical failure in patients with adenocarcinoma of the prostate
Select
11-0621 A Phase I/II Study of Docetaxel, Prednisone and Pazopanib in Men with Metastatic Castrate-resistant cancer and poor-risk features.
Select
12-1841 PHASE II EVALUATION OF MR-GUIDED LASER-INDUCED INTERSTITIAL THERMAL THERAPY (LITT) FOR PROSTATE CANCER
Select
13-0385 S1216: A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer
IRB13-0756 Quantitative DCEMRI of Prostate Cancer ¿ Correlation with Gold Standards
12803B Quality of Life after Radical Prostatectomy
12278A Clinical Urology Research Screening Protocol
Select
15244B IRB 15244B: CALGB 90203: Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
14934A Radiotherapy for Prostate Cancer: Dosimetric and Clinical Outcomes in the IMRT Era

To learn more about cancer clinical trials or to make an appointment, call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials). Although our objective is to provide an updated listing of clinical trials, please note that a listing here does not guarantee that a trial is open or available to any specific patient. Additional trials may be available that are not listed. Complete information is available only from a treating physician.